MCID: CHR057
MIFTS: 28

Chronic Laryngitis malady

Category: Respiratory diseases

Aliases & Classifications for Chronic Laryngitis

About this section

Aliases & Descriptions for Chronic Laryngitis:

Name: Chronic Laryngitis 10 12 65

Classifications:



External Ids:

Disease Ontology10 DOID:11797
ICD1027 J37.0
ICD9CM29 476.0
NCIt42 C26975
UMLS65 C0155836

Summaries for Chronic Laryngitis

About this section
Disease Ontology:10 A laryngitis in which symptoms last longer than three weeks. Gastroesophageal reflux, and lingering bronchitis can cause the disease.

MalaCards based summary: Chronic Laryngitis is related to laryngotracheitis and vulvar proximal-type epithelioid sarcoma. An important gene associated with Chronic Laryngitis is ATP4A (ATPase H+/K+ Transporting Alpha Subunit), and among its related pathways are Proton Pump Inhibitor Pathway, Pharmacodynamics and Platelet Aggregation Inhibitor Pathway, Pharmacodynamics. Affiliated tissues include endothelial, lung and smooth muscle, and related mouse phenotype digestive/alimentary.

Related Diseases for Chronic Laryngitis

About this section

Diseases in the Laryngitis family:

chronic laryngitis Viral Laryngitis
Acute Laryngitis

Diseases related to Chronic Laryngitis via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50)    (show all 89)
idRelated DiseaseScoreTop Affiliating Genes
1laryngotracheitis10.5
2vulvar proximal-type epithelioid sarcoma10.3ATP4A, HRH2
3adult central nervous system germinoma10.3ATP4A, HRH2
4mammary paget's disease10.3ATP4A, HRH2
5fungal esophagitis10.3ATP4A, CYP2C19
6hepatic vein thrombosis10.3ATP12A, ATP4A
7phlebotomus fever10.3ATP12A, ATP4A
8venezuelan equine encephalitis10.3ATP12A, ATP4A
9subareolar duct papillomatosis10.3ATP12A, ATP4A
10acute cystitis10.3ATP12A, ATP4A
11epiglottitis10.3ATP12A, ATP4A
12crohn's colitis10.3ATP12A, ATP4A
13toxicodendron dermatitis10.3ATP12A, ATP4A
14acute chest syndrome10.3ATP12A, ATP4A
15esophagitis10.3ATP12A, ATP4A
16cervical dystonia10.3ATP12A, ATP4A
17duodenal obstruction10.3ATP12A, ATP4A
18krukenberg carcinoma10.3ATP12A, ATP4A
19prostate carcinoma in situ10.3ATP12A, ATP4A
20gastrointestinal tuberculosis10.3ATP12A, ATP4A
21peritoneal serous papillary adenocarcinoma10.3ATP12A, ATP4A
22lipid pneumonia10.3CYP2C19, HRH2
23spinocerebellar ataxia 1810.3ATP12A, ATP4A
24ileitis10.3ATP12A, ATP4A
25eosinophilic gastroenteritis10.3ATP12A, ATP4A
26basophilic carcinoma10.3ATP12A, ATP4A
27protein-losing enteropathy10.2ATP12A, ATP4A
28bronchus cancer10.2ATP12A, ATP4A
29hcl-v10.2ATP12A, ATP4A
30cerebral-cerebellar-coloboma syndrome, x-linked10.2ATP12A, ATP4A
31angiodysplasia10.2ATP12A, ATP4A
32speech disorder10.2ATP12A, ATP4A
33megacolon10.2ATP12A, ATP4A
34labyrinthine unilateral reactive loss10.2ATP12A, ATP4A
35anterior compartment syndrome10.2ATP12A, ATP4A
36pyomyositis10.2ATP12A, ATP4A
37mansonelliasis10.2CYP2C19, HRH2
38partial optic atrophy10.2CYP2C19, HRH2
39retinal dystrophy with inner retinal dysfunction and ganglion cell abnormalities10.1CYP2C19, HRH2
40primary lacrimal atrophy10.1ATP4A, CYP2C19, HRH2
41postmenopausal atrophic vaginitis10.1CYP2C19, HRH2
42pediatric infratentorial ependymoma10.1ATP4A, CYP2C19, HRH2
43periductal breast myoepitheliosis10.1ATP12A, ATP4A, HRH2
44bladder lateral wall cancer10.1ATP12A, ATP4A, HRH2
45infiltrating bladder lymphoepithelioma-like carcinoma10.1ATP12A, ATP4A, HRH2
46lymphoma, malt, somatic10.1ATP12A, ATP4A
47vestibulocochlear nerve disease10.1ATP12A, ATP4A, CYP2C19
48peritoneum cancer10.1CYP2C19, HRH2
49farber lipogranulomatosis10.0ATP12A, ATP4A
50gastroenteritis10.0CYP2C19, HRH2

Graphical network of the top 20 diseases related to Chronic Laryngitis:



Diseases related to chronic laryngitis

Symptoms for Chronic Laryngitis

About this section

Drugs & Therapeutics for Chronic Laryngitis

About this section

Drugs for Chronic Laryngitis (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 29)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1
Esomeprazoleapproved, investigationalPhase 4308161796-78-74594, 9579578
Synonyms:
( -)-Omeprazole
(-)-Omeprazole
(-)-omeprazole
(S)-(-)-Omeprazole
(S)-(−)-omeprazole
(S)-Omeprazole
(S)-omeprazole
(s)-omeprazole
(−)-omeprazole
119141-88-7
119141-89-8
131959-78-9
172964-80-6
193469-77-1
2-(((3,5-Dimethyl-4-methoxy-2-pyridyl)methyl)sulfinyl)-5-methoxy-1H-benzimidazole
2-({[3,5-dimethyl-4-(methyloxy)pyridin-2-yl]methyl}sulfinyl)-5-(methyloxy)-1H-benzimidazole
326602-80-6
5-Methoxy-2-(((4-methoxy-3,5-dimethyl-2-pyridyl)methyl)sulfinyl)benzimidazole
5-Methoxy-2-((S)-((4-methoxy-3,5-dimethyl-2-pyridyl)methyl)sulfinyl)benzimidazole
5-Methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl]sulfinyl]-1H-benzimidazole
5-Methoxy-2[(4-methoxy-3,5-dimethyl-2-pyridyl)methylsulfinyl]-1H-benzimidazole
5-methoxy-2-{(S)-[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl}-1H-benzimidazole
5-methoxy-2-{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl}-1-methyl-1H-benzimidazole
5-methoxy-2-{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl}-1H-benzimidazole
6-methoxy-2-[(4-methoxy-3,5-dimethylpyridin-2-yl)methylsulfinyl]-1H-benzimidazole
6-methoxy-2-{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl}-1H-benzimidazole
73590-58-6
AC-401
AC1L1IIJ
AGI-010
AKOS005066653
AULCER
Antra
Antra MUPS
Audazol
Axagon
BIDD:GT0020
BIDD:GT0189
BPBio1_000425
BRD-A55962179-001-04-9
BSPBio_000385
Belmazol
Bio-0888
C07324
CAS-73590-58-6
CCRIS 7099
CHEBI:50275
CHEBI:519601
CHEBI:7772
CHEMBL1503
CID4594
CID9568614
CID9579578
CPD000058847
Ceprandal
D00455
D07917
DB00338
DB00736
DM-3458
Danlox
Demeprazol
Desec
Dizprazol
Dudencer
Elgam
Emeproton
Emilok
Epirazole
Erbolin
Esomeprazol
Esomeprazole
Esomeprazole (INN)
Esomeprazole Sodium
Esomeprazole [INN:BAN]
Esomeprazolum
Esomperazole
Esopral
Exter
Gasec
Gastrimut
Gastroloc
Gibancer
H 168-68
H 168/68
H-168/68
H168/68
HMS1528I05
HMS1569D07
HMS2052G17
HMS2090E16
HMS2090F11
HSDB 3575
I06-0705
IDI1_032523
InChI=1/C17H19N3O3S/c1-10-8-18-15(11(2)16(10)23-4)9-24(21)17-19-13-6-5-12(22-3)7-14(13)20-17/h5-8H,9H2,1-4H3,(H,19,20
Indurgan
Inexium paranova
Inexium paranova (TN)
Inhibitron
Inhipump
LS-185188
LS-7629
Lensor
Logastric
Lomac
Losec
Losec, Omesec, Prilosec, Zegerid, Omeprazole
Lucen
MLS000069373
MLS001076112
MLS001424148
Maybridge4_002645
Mepral
 
Miol
Miracid
MolPort-003-666-741
MolPort-003-807-515
MolPort-003-849-702
MolPort-005-943-880
Mopral
Morecon
NCGC00016925-01
NCGC00016925-02
NCGC00021522-03
NCGC00021522-04
NCGC00021522-05
Nexiam
Nexium
Nexium Control
Nexium I.V.
Nexium IV
Nilsec
Nopramin
Nuclosina
O0359
O104_SIGMA
OMEP
OMZ
Ocid
Olexin
Olit
Omapren
Omebeta
Omebeta 20
Omed
Omegast
Omepradex
Omepral
Omeprazol
Omeprazol [INN-Spanish]
Omeprazole (JAN/USP/INN)
Omeprazole [USAN:INN:BAN:JAN]
Omeprazole delayed-release
Omeprazole magnesium
Omeprazolum
Omeprazolum [INN-Latin]
Omeprazon
Omeprazone
Omeprol
Omesek
Omez
Omezol
Omezolan
Omid
Omisec
Omizac
Ompanyt
Ortanol
Osiren
Ozoken
Paprazol
Parizac
Pepticum
Pepticus
Peptilcer
Perprazole
Prazentol
Prazidec
Prazolit
Prestwick0_000493
Prestwick1_000493
Prestwick2_000493
Prestwick3_000493
Prestwick_808
Prilosec
Prilosec (TN)
Prilosec OTC
Procelac
Proclor
Prysma
Ramezol
Regulacid
Result
S1389_Selleck
SAM001246900
SAN-15
SMR000058847
SPBio_002306
STK623746
Sanamidol
Secrepina
TL8005099
Tedec Ulceral
UNII-KG60484QX9
UNII-N3PA6559FT
UPCMLD-DP075
UPCMLD-DP075:001
Ulceral
Ulcesep
Ulcometion
Ulcozol
Ulcsep
Ulsen
Ultop
Ulzol
Victrix
ZINC04693574
ZINC04693575
Zefxon
Zegerid
Zepral
Zimor
Zoltum
esomeprazol
esomeprazole
esomeprazolum
omeprazole
Ésoméprazole
2AntacidsPhase 41453
3
Proton pump inhibitorsPhase 4958
Synonyms:
 
PPIs
4Gastrointestinal AgentsPhase 46401
5Anti-Ulcer AgentsPhase 41453
6
PerphenazineapprovedPhase 2, Phase 38358-39-94748
Synonyms:
.gamma.-[4-(.beta.-Hydroxyethyl)piperazin-1-yl]propyl-2-chlorophenothiazine
1',1-(2-Idrossietil)-4,3-(2-cloro-10-fenotiazil)propilpiperazina
1',1-(2-Idrossietil)-4,3-(2-cloro-10-fenotiazil)propilpiperazina [Italian]
1-(2-Hydroxyethyl)-4-(3-(2-chloro-10-phenothiazinyl)propyl)piperazine
1-(2-Hydroxyethyl)-4-[3-(2-chloro-10-phenothiazinyl)propyl]piperazine
1-Piperazineethanol, 4-[3-(2-chlorophenothiazin-10-yl)propyl]-, trihydrochloride
2-(4-[3-(2-Chloro-10H-phenothiazin-10-yl)propyl]-1-piperazinyl)ethanol
2-(4-[3-(2-chloro-10H-Phenothiazin-10-yl)propyl]-1-piperazinyl)ethanol
2-Chloro-10-(3-(1-(2-hydroxyethyl)-4-piperazinyl)propyl)phenothiazine
2-Chloro-10-(3-(4-(2-hydroxyethyl)piperazin-1-yl)propyl)phenothiazine
2-Chloro-10-3-(1-(2-hydroxyethyl)-4-piperazinyl)propyl phenothiazine
2-Chloro-10-3-[1-(2-hydroxyethyl)-4-piperazinyl]propyl phenothiazine
2-Chloro-10-[3-[4-(2-hydroxyethyl)piperazin-1-yl]propyl]phenothiazine
2-[4-[3-(2-Chlorophenothiazin-10-yl)propyl]piperazin-1-yl]ethanol
2-chloro-10-(3-(4-(2-Hydroxyethyl)piperazin-1-yl)propyl)phenothiazine
2-{4-[3-(2-Chloro-phenothiazin-10-yl)-propyl]-piperazin-1-yl}-ethanol
2-{4-[3-(2-chloro-10H-phenothiazin-10-yl)propyl]piperazin-1-yl}ethanol
4-(3-(2-Chlorophenothiazin-10-yl)propyl)-1-piperazineethanol
4-[3-(2-Chloro-10H-phenothiazin-10-yl)propyl]-1-piperazineethanol
4-[3-(2-Chlorophenothiazin-10-yl)propyl]-1-piperazineethanol
4-[3-(2-chloro-10H-Phenothiazin-10-yl)propyl]-1-piperazineethanol
58-39-9
AB00052390
AC-12196
AC1L1IVB
AI3-50151
AKOS000664046
Apo-Perphenazine
BAS 00139131
BIDD:GT0150
BPBio1_000188
BRD-K10995081-001-05-5
BSPBio_000170
BSPBio_002376
C07427
C21H26ClN3OS
CAS-58-39-9
CHEBI:8028
CHEMBL567
CID4748
CPD000058180
Chlorperphenazine
Chlorpiprazine
D00503
D010546
DB00850
Decentan
DivK1c_000880
EINECS 200-381-5
EU-0072164
EU-0100930
Emesinal
Etaperazin
Etaperazine
Ethaperazine
Etrafon-A
Etrafon-Forte
F-Mon
F-mon
Fentazin
HMS1568I12
HMS1922M14
HMS2093M15
HMS502L22
HSDB 3379
I06-1508
IDI1_000880
KBio1_000880
KBio2_002090
KBio2_004658
KBio2_007226
 
KBio3_001596
KBioGR_001445
KBioSS_002090
L000919
LS-112185
Lopac-P-6402
Lopac0_000930
MLS000069637
MLS001146929
MolPort-001-727-942
NCGC00015826-01
NCGC00015826-02
NCGC00015826-03
NCGC00015826-06
NCGC00015826-10
NCGC00024092-03
NCGC00024092-04
NCGC00024092-05
NCGC00024092-06
NINDS_000880
NSC 150866
NSC150866
Oprea1_603835
P 6402
P6402_SIGMA
PZC
Perfenazina
Perfenazina [INN-Spanish]
Perfenazina [Italian]
Perfenazine
Perphenan
Perphenazin
Perphenazine
Perphenazine (JP15/USP/INN)
Perphenazine [INN:BAN:JAN]
Perphenazine [Trilafon]
Perphenazine enanthate
Perphenazine heptanoate
Perphenazine maleate
Perphenazinum
Perphenazinum [INN-Latin]
Perphénazine
Prestwick0_000125
Prestwick1_000125
Prestwick2_000125
Prestwick3_000125
Prestwick_536
SAM002264637
SCH-3940
SMR000058180
SPBio_001603
SPBio_002109
SPECTRUM1503934
SR-01000000137-4
STK019818
STOCK1S-21551
Sch 3940
Spectrum2_001602
Spectrum3_000758
Spectrum4_000843
Spectrum5_001493
Spectrum_001610
Thilatazin
Tranquisan
Trifaron
Trilafon
Trilifan
Triphenot
UNII-FTA7XXY4EZ
WLN: T C666 BN ISJ EG B3- AT6N DNTJ D2Q
gamma-(4-(beta-Hydroxyethyl)piperazin-1-yl)propyl-2-chlorophenothiazine
nchembio873-comp26
perphenazine
7
AmitriptylineapprovedPhase 2, Phase 310050-48-62160
Synonyms:
10,11-Dihydro-5-(gamma-dimethylaminopropylidene)-5H-dibenzo(a,d)cycloheptene
10,11-Dihydro-N,N-dimethyl-5H-dibenzo(a,d)heptalene-delta(5),gamma-propylamine
10,11-dihydro-5-(gamma-Dimethylaminopropylidene)-5H-dibenzo(a,D)cycloheptene
10,11-dihydro-5-(gamma-dimethylaminopropylidene)-5H-dibenzo[a,d]cycloheptene
10,11-dihydro-N,N-Dimethyl-5H-dibenzo(a,D)heptalene-delta(5),gamma-propylamine
17086-03-2 (pamoate (2:1))
3-(10,11-Dihydro-5H-dibenzo(a,d)cyclohepten-5-yliden)-N,N-dimethylpropylamin
3-(10,11-dihydro-5H-Dibenzo(a,D)cyclohepten-5-ylidene)-N,N-dimethyl-1-propanamine
3-(10,11-dihydro-5H-Dibenzo[a,D]cyclohepten-5-ylidene)-N,N-dimethylpropan-1-amine
3-(10,11-dihydro-5H-dibenzo[a,d][7]annulen-5-ylidene)-N,N-dimethylpropan-1-amine
30227-34-0 (maleate (1:1))
5-(3'-Dimethylaminopropylidene)-dibenzo-(a,d)(1,4)-cycloheptadiene
5-(3'-Dimethylaminopropylidene)-dibenzo-[a,d][1,4]-cycloheptadiene
5-(3-Dimethylaminopropylidene)-10,11-dihydro-5H-dibenzo(a,D)cycloheptatriene
5-(3-Dimethylaminopropylidene)-10,11-dihydro-5H-dibenzo(a,D)cycloheptene
5-(3-Dimethylaminopropylidene)-10,11-dihydro-5H-dibenzo(a,d)cycloheptatriene
5-(3-Dimethylaminopropylidene)-10,11-dihydro-5H-dibenzo(a,d)cycloheptene
5-(3-Dimethylaminopropylidene)-5H-dibenzo[a,d]-10,11-dihydrocycloheptene
5-(3-dimethylaminopropylidene)dibenzo[a,d][1,4]-cycloheptadiene
5-(gamma-Dimethylaminopropylidene)-10,11-dihydro-5H-dibenzo(a,d)cycloheptene
5-(gamma-Dimethylaminopropylidene)-5H-Dibenzo[a,d][1,4]cycloheptadiene
5-(gamma-Dimethylaminopropylidene)-5H-dibenzo(a,d)(1,4)cycloheptadiene
5-(gamma-Dimethylaminopropylidene)-5H-dibenzo[a,D][1,4]cycloheptadiene
5-(gamma-Dimethylaminopropylidene)-5H-dibenzo[a,d]10,11-dihydrocycloheptene
5-(gamma-Dimethylaminopropylidine)-5H-dibenzo(a,d)(1,4)cycloheptadiene
50-48-6
549-18-8 (hydrochloride)
AB00514631
AC1L1D20
AKOS000512694
Adepress
Adepril
Amitid
Amitril
Amitriprolidine
Amitriptilina
Amitriptilina [INN-Spanish]
Amitriptilina [Italian]
Amitriptylin
Amitriptylin [German]
Amitriptyline
Amitriptyline (INN)
Amitriptyline HCL
Amitriptyline Hydrochloride
Amitriptyline [INN:BAN]
Amitriptylinum
Amitriptylinum [INN-Latin]
Amitryptiline
Amitryptyline
Amytriptiline
Amytriptylin
BAS 00269727
BIDD:GT0115
BPBio1_000317
BRD-K53737926-003-05-4
BRN 2217885
BSPBio_000287
BSPBio_001836
C06824
CAS-549-18-8
CCRIS 9174
CHEBI:2666
CHEMBL629
CID2160
D07448
DB00321
Damilan
Damilen
Damitriptyline
DivK1c_000766
EINECS 200-041-6
Elanil
 
Elavil
Endep
Flavyl
Hexathane
Horizon
IDI1_000766
KBio1_000766
KBio2_000424
KBio2_002261
KBio2_002992
KBio2_004829
KBio2_005560
KBio2_007397
KBio3_001336
KBio3_002741
KBioGR_000592
KBioGR_002261
KBioSS_000424
KBioSS_002262
L001041
LS-60747
Lantron
Laroxil
Laroxyl
Laroxyl (TN)
Lentizol
Levate
Lopac-A-8404
Lopac0_000112
MK 230
MolPort-001-662-651
N 750
NCGC00015095-01
NCGC00015095-02
NCGC00015095-03
NCGC00015095-10
NCGC00024433-04
NINDS_000766
NSC169910
Oprea1_479304
PDSP1_001564
PDSP2_001548
Prestwick0_000074
Prestwick1_000074
Prestwick2_000074
Prestwick3_000074
Proheptadiene
Redomex
Ro 4-1575
SPBio_000082
SPBio_002208
STK525215
STOCK1S-56825
Saroten
Sarotex
Seroten
Spectrum2_000101
Spectrum3_000298
Spectrum4_000146
Spectrum5_000806
Spectrum_000044
Sylvemid
TP0
Triptanol
Triptilin
Triptisol
Tryptanol
Tryptizol
UNII-1806D8D52K
[3-(10,11-Dihydro-dibenzo[a,d]cyclohepten-5-ylidene)-propyl]-dimethyl-amine
amitriptyline
cMAP_000001
dAmitriptyline
8Neurotransmitter AgentsPhase 2, Phase 314795
9Tranquilizing AgentsPhase 2, Phase 33597
10Neurotransmitter Uptake InhibitorsPhase 2, Phase 32857
11Peripheral Nervous System AgentsPhase 2, Phase 318510
12Central Nervous System DepressantsPhase 2, Phase 310016
13Psychotropic DrugsPhase 2, Phase 35501
14Contraceptives, OralPhase 2, Phase 33734
15Adrenergic AgentsPhase 2, Phase 34204
16Antipsychotic AgentsPhase 2, Phase 32130
17AnalgesicsPhase 2, Phase 39358
18Amitriptyline, perphenazine drug combinationPhase 2, Phase 3100
19Analgesics, Non-NarcoticPhase 2, Phase 35184
20Antidepressive AgentsPhase 2, Phase 32367
21Antidepressive Agents, TricyclicPhase 2, Phase 3250
22
Omeprazoleapproved, investigational32173590-58-64594
Synonyms:
( -)-Omeprazole
(-)-Omeprazole
(S)-(-)-Omeprazole
(S)-Omeprazole
119141-89-8
131959-78-9
172964-80-6
2,3,5-Trimethylpyridine/Omeprazole
2-(((3,5-Dimethyl-4-methoxy-2-pyridyl)methyl)sulfinyl)-5-methoxy-1H-benzimidazole
2-({[3,5-dimethyl-4-(methyloxy)pyridin-2-yl]methyl}sulfinyl)-5-(methyloxy)-1H-benzimidazole
5-Methoxy-2-(((4-methoxy-3,5-dimethyl-2-pyridyl)methyl)sulfinyl)benzimidazole
5-Methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl]sulfinyl]-1H-benzimidazole
5-Methoxy-2[(4-methoxy-3,5-dimethyl-2-pyridyl)methylsulfinyl]-1H-benzimidazole
5-methoxy-2-{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl}-1H-benzimidazole
6-methoxy-2-[(4-methoxy-3,5-dimethylpyridin-2-yl)methylsulfinyl]-1H-benzimidazole
73590-58-6
AC-401
AC1L1IIJ
AGI-010
AKOS005066653
AULCER
Antra
Antra MUPS
Audazol
Aulcer
Axagon
BIDD:GT0189
BPBio1_000425
BRD-A55962179-001-04-9
BSPBio_000385
Being Well Omeprazole
Belmazol
Bio-0888
C07324
CAS-73590-58-6
CCRIS 7099
CHEBI:519601
CHEBI:7772
CHEMBL1503
CID4594
CPD000058847
Care One Omeprazole
Ceprandal
D00455
DB00338
DB00736
DM-3458
Danlox
Demeprazol
Desec
Dg Health Omeprazole
Dizprazol
Dudencer
Elgam
Emeproton
Emilok
Epirazole
Equaline Omeprazole
Equate Omeprazole Delayed Release acid reducer
Erbolin
Esomeprazole
Esomperazole
Esopral
Exchange Select Omeprazole
Exter
Family Wellness Omeprazole
Formu Care Omeprazole
Fulton Street Market Omeprazole
Gasec
Gastrimut
Gastroloc
Gibancer
Good Neighbor Pharmacy Omeprazole
Good Sense Omeprazole
H 168-68
H 168/68
H-168/68
H168/68
HMS1528I05
HMS1569D07
HMS2052G17
HMS2090E16
HMS2090F11
HSDB 3575
Harmon Face Values Omeprazole
Health Mart Omeprazole
Healthy Accents Omeprazole
I06-0705
IDI1_032523
Indurgan
Inhibitron
Inhipump
Kirkland Signature Omeprazole
LS-7629
Leader Omeprazole
Lensor
Logastric
Lomac
Losec
Losec, Omesec, Prilosec, Zegerid, Omeprazole
Lucen
MLS000069373
MLS001076112
MLS001424148
Maybridge4_002645
Members Mark Omeprazole
Mepral
Miol
Miracid
MolPort-003-666-741
MolPort-003-807-515
MolPort-003-849-702
Mopral
 
Morecon
NCGC00016925-01
NCGC00016925-02
NCGC00021522-03
NCGC00021522-04
NCGC00021522-05
Nexiam
Nexium
Nexium IV
Nilsec
Nopramin
Nuclosina
O0359
O104_SIGMA
OMEP
OMP
OMZ
Ocid
Olex
Olexin
Olit
Omapren
Omebeta
Omebeta 20
Omed
Omegast
Omepradex
Omepral
Omeprazol
Omeprazol [INN-Spanish]
Omeprazole
Omeprazole (JAN/USP/INN)
Omeprazole Delayed Release
Omeprazole Delayed-release
Omeprazole Magnesium
Omeprazole Pellets
Omeprazole [USAN:INN:BAN:JAN]
Omeprazole delayed-release
Omeprazole magnesium
Omeprazole sodium
Omeprazolum
Omeprazolum [INN-Latin]
Omeprazon
Omeprazone
Omeprol
Omesec
Omesek
Omez
Omezol
Omezolan
Omid
Omisec
Omizac
Ompanyt
Ortanol
Osiren
Ozoken
Paprazol
Parizac
Pepticum
Pepticus
Peptilcer
Prazentol
Prazidec
Prazolit
Preferred Plus Omeprazole
Prestwick0_000493
Prestwick1_000493
Prestwick2_000493
Prestwick3_000493
Prestwick_808
Prilosec
Prilosec (TN)
Prilosec OTC
Procelac
Proclor
Prysma
Quality Choice Omeprazole
Ramezol
Regulacid
Result
S1389_Selleck
SAM001246900
SAN-15
SMR000058847
SPBio_002306
STK623746
Sanamidol
Secrepina
Shoprite Omeprazole
Simply Right Omeprazole
Smart Sense Omeprazole
Sunmark Omeprazole
TL8005099
Tedec Ulceral
Topcare Omeprazole
UNII-KG60484QX9
UPCMLD-DP075
UPCMLD-DP075:001
Ulceral
Ulcesep
Ulcometion
Ulcozol
Ulcsep
Ulsen
Ultop
Ulzol
Victrix
Zefxon
Zegerid
Zepral
Zimor
Zoltum
esomeprazol
omeprazole
23
Amoxicillinapproved39126787-78-033613, 2171
Synonyms:
(-)-6-(2-Amino-2-(P-hydroxyphenyl)acetamido)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo-(3.2.0)heptane-2-carboxylic acid
(2S,5R,6R)-6-[[(2R)-2-amino-2-(4-hydroxyphenyl)acetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid
(2S,5R,6R)-6-{[(2R)-2-amino-2-(4-hydroxyphenyl)acetyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid
26787-78-0
33911-69-2
34642-77-8 (mono-hydrochloride salt)
4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 6-(2-amino-2-(p-hydroxyphenyl)acetamido)-3,3-dimethyl-7-oxo-, D- (8CI)
6-(D-(-)-alpha-Amino-p-hydroxyphenylacetamido)penicillanic acid
6-(D-(-)-p-Hydroxy-alpha-aminobenzyl)penicillin
6-(P-Hydroxy-alpha-aminophenylacetamido)penicillanic acid
6-(a-Amino-4-hydroxyphenylacetamido)penicillanic acid
6-(p-Hydroxy-alpha-aminophenylacetamido)penicillanic acid
6-(p-hydroxy-α-aminophenylacetamido)penicillanic acid
6-[[Amino(4-hydroxyphenyl)acetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid, 9CI
61336-70-7 (TRIHYDRATE)
6beta-[(2R)-2-amino-2-(4-hydroxyphenyl)acetamido]-2,2-dimethylpenam-3alpha-carbonyl
6beta-[(2R)-2-amino-2-(4-hydroxyphenyl)acetamido]-2,2-dimethylpenam-3alpha-carboxylic acid
71447-36-4
81030-75-3
AC-12263
AC1L1PY2
AMC
AMOXICILLIN CRYSTALLINE
AMOXICILLIN PEDIATRIC
AMPC
AUGMENTIN '125'
AUGMENTIN '200'
AUGMENTIN '250'
AUGMENTIN '400'
AUGMENTIN '500'
AUGMENTIN '875'
AUGMENTIN ES-600
AX
Actimoxi
Almodan
Ambap26787-78-0
Amix
Amoclen
Amolin
Amopen
Amopenixin
Amoram
Amox
Amox 250 Cap 250mg
Amox 500 Cap 500mg
Amox S 125 Sus 125mg/5ml
Amox S 250 Sus 250mg/5ml
Amoxi
Amoxi-Mast
Amoxi-mast
Amoxibiotic
Amoxicaps
Amoxicilina
Amoxicilina [INN-Spanish]
Amoxicillin
Amoxicillin (INN)
Amoxicillin (TN)
Amoxicillin (anhydrous)
Amoxicillin (inn)
Amoxicillin Extended-release
Amoxicillin Trihydrate
Amoxicillin and clavulanate potassium
Amoxicillin anhydrous
Amoxicillin pediatric
Amoxicillin sodium
Amoxicillin trihydrate
Amoxicillin(usan)
Amoxicilline
Amoxicilline [INN-French]
Amoxicilline [INN]
Amoxicilline [inn]
Amoxicillinum
Amoxicillinum [INN-Latin]
Amoxid
Amoxiden
Amoxil
Amoxivet
Amoxycillin
Amoxycillin Trihydrate
Amoxycillin trihydrate
Amoxycillin, BAN
Amoxymed
Amrit
Anemolin
Apo-Amoxi
Apo-Amoxi Cap 250mg
Apo-Amoxi Cap 500mg
Apo-Amoxi Pwr for Susp 125mg/5ml
Apo-Amoxi Pwr for Susp 250mg/5ml
Apo-amoxi
Apo-amoxi sugar free
Aspenil
Augmentinxr
BL-P 1410
BLP 1410
BPBio1_000499
BRD-K55044200-001-03-9
BRL 2333
 
BRL-2333
BSPBio_000453
Biomox
Bristamox
C06827
CHEBI:2676
CHEBI:53712
CHEMBL1082
CID33613
CPD000058707
Cemoxin
Clamoxyl
Clamoxyl (SKB)
D-(-)-alpha-Amino-p-hydroxybenzyl penicillin
D-(-)-alpha-Amino-p-hydroxybenzylpenicillin
D-(alpha-Amino-p-hydroxybenzyl)penicillin
D-2-Amino-2-(4-hydroxyphenyl)acetamidopenicillanic acid
D-Amoxicillin
D07452
DB01060
Delacillin
DisperMox
Dispermox
EINECS 248-003-8
Efpenix
Flemoxin
Galenamox
Gen-Amoxicillin 250mg
Gen-Amoxicillin 500mg
HMS1569G15
HSDB 3204
Hiconcil
Histocillin
Hydroxyampicillin
Ibiamox
Imacillin
LS-149721
Lamoxy
Larotid
MLS000028632
MLS002222248
Metafarma capsules
Metifarma capsules
MolPort-003-981-182
MolPort-005-933-687
Moxacin
Moxal
Moxatag
NCGC00179554-01
NSC 277174
NSC277174
Novamoxin
Novamoxin Cap 250mg
Novamoxin Cap 500mg
Novamoxin Sus 125mg/5ml
Novamoxin Sus 250mg/5ml
Nu-Amoxi Cap 250mg
Nu-Amoxi Cap 500mg
Nu-Amoxi Sus 125/5ml
Nu-Amoxi Sus 250mg/5ml
Ospamox
P-Hydroxyampicillin
PHL-amoxicillin
PMS-amoxicillin
Pamoxicillin
Piramox
Polymox
Prestwick0_000357
Prestwick1_000357
Prestwick2_000357
Prestwick3_000357
Prestwick_713
Prevpac
Pro Amox Pwr for Oral Susp 125mg/5ml
Pro Amox-250 Cap 250mg
Pro Amox-500 Cap 500mg
Pro-Amox-250 Orl Sus 250mg/5ml
R-Hydroxyampicillin
Rimoxallin
Ro 10-8756
Robamox
SAM002264592
SMR000058707
SPBio_002374
Sauracillin
Sawamox PM
Sumox
Tolodina
Trimox
Unicillin
Utimox
Vetramox
Wymox
Zimox
alpha-Amino-p-hydroxybenzylpenicillin
alpha-amino-P-Hydroxybenzylpenicillin
amoxicillanyl
amoxicillin
p-Hydroxyampicillin
α-amino-p-hydroxybenzylpenicillin
24Beta-Lactamase Inhibitors245
25Clavulanic Acids147
26Anti-Infective Agents17220
27Mitogens1386
28Amoxicillin-Potassium Clavulanate Combination121
29Anti-Bacterial Agents9140

Interventional clinical trials:

idNameStatusNCT IDPhase
1Chronic Posterior Laryngitis With Suspected Laryngopharyngeal RefluxCompletedNCT00628667Phase 4
2Treatment of Chronic Laryngitis With AmitriptylineNot yet recruitingNCT02552225Phase 2, Phase 3
3Trial of the Treatment of Chronic Laryngitis With AmitryptilineTerminatedNCT02434523Phase 2, Phase 3
4Laryngeal and Esophageal EGF-r Expression in Patients With Reflux LaryngitisCompletedNCT01806220
5Salivary Epidermal Growth Factor (EGF) Concentration Before and After Treatment of Reflux LaryngitisCompletedNCT01389401
6Special Drug Use Investigation for CLAVAMOX® (Amoxicillin/Clavulanate) Pediatrics Dry Syrup (Every Indication Excluded Otitis Media)CompletedNCT01406275

Search NIH Clinical Center for Chronic Laryngitis

Genetic Tests for Chronic Laryngitis

About this section

Anatomical Context for Chronic Laryngitis

About this section

MalaCards organs/tissues related to Chronic Laryngitis:

33
Endothelial, Lung, Smooth muscle, Brain, Colon, Liver, Placenta

Animal Models for Chronic Laryngitis or affiliated genes

About this section

MGI Mouse Phenotypes related to Chronic Laryngitis:

38
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:00053818.5ATP12A, ATP4A, HRH2, KRT19

Publications for Chronic Laryngitis

About this section

Articles related to Chronic Laryngitis:

(show all 50)
idTitleAuthorsYear
1
Patterns of Weakness, Classification of Motor Neuron Disease, and Clinical Diagnosis of Sporadic Amyotrophic Lateral Sclerosis. (26515618)
2015
2
Successful desensitization of a patient with aplastic anemia to antithymocyte globulin. (25730287)
2015
3
Growth hormone significantly increases the adult height of children with idiopathic short stature: comparison of subgroups and benefit. (25075207)
2014
4
Screening for hypopituitarism in 509 patients with traumatic brain injury or subarachnoid hemorrhage. (23980725)
2014
5
Neuropathological correlate of the "concentric target sign" in MRI of HIV-associated cerebral toxoplasmosis. (23440973)
2013
6
Polymorphisms in the base excision repair pathway modulate prognosis of platinum-based chemotherapy in advanced non-small cell lung cancer. (23479135)
2013
7
Expression of genes involved in xenobiotic metabolism and transport in end-stage liver disease: up-regulation of ABCC4 and CYP1B1. (23087145)
2012
8
Autoimmune hepatitis in the postpartum period. (22481086)
2012
9
Paradoxical cardiovascular effects of implementing adaptive emotion regulation strategies in generalized anxiety disorder. (22218164)
2012
10
Reduced avian virulence and viremia of West Nile virus isolates from Mexico and Texas. (21976584)
2011
11
Intra-articular nodular fasciitis of the shoulder: a case report and review of the literature. (21603874)
2011
12
Obstructive jaundice caused by a portal cavernoma. (21191741)
2010
13
Cystatin C as an index of cerebral small vessel disease: results of a cross-sectional study in community-based Japanese elderly. (19832902)
2010
14
Characterization of a new genotype and serotype of infectious bronchitis virus in Western Africa. (19625463)
2009
15
NS5 of dengue virus mediates STAT2 binding and degradation. (19279106)
2009
16
Matrix Metalloproteinases (MMP-2 and MMP-9) and cyclooxygenase-2 (COX-2) expressions in vocal fold polyps. (17624726)
2009
17
Trim11 increases expression of dopamine beta-hydroxylase gene by interacting with Phox2b. (18275850)
2008
18
Serum vascular endothelial growth factor/soluble vascular endothelial growth factor receptor 1 ratio is an independent prognostic marker in pancreatic cancer. (18665074)
2008
19
Air exposure induced squamous metaplasia of human limbal epithelium. (18172087)
2008
20
Predictive factors for interferon and ribavirin combination therapy in patients with chronic hepatitis C. (18069766)
2007
21
Improved detection of bladder carcinoma cells in voided urine by standardized microsatellite analysis. (17373664)
2007
22
Bronchiectasis in two pediatric patients with Rothmund-Thomson syndrome. (17250521)
2007
23
Acetoxycycloheximide (E-73) rapidly induces apoptosis mediated by the release of cytochrome c via activation of c-Jun N-terminal kinase. (15670574)
2005
24
Macrolide antibiotics and bronchiolitis obliterans following lung transplantation. (16307505)
2005
25
Surveillance of acute hepatitis C in Cairo, Egypt. (15977225)
2005
26
Tracheal agenesis in newborns. (15475795)
2004
27
Influence of transforming growth factor-beta2 on production of tumor necrosis factor-alpha and interferon-gamma from placenta of intrahepatic cholestasis of pregnancy]. (15196415)
2004
28
Variation in USF1 shows haplotype effects, gene : gene and gene : environment associations with glucose and lipid parameters in the European Atherosclerosis Research Study II. (15175273)
2004
29
IL-18BPa:Fc cooperates with immunosuppressive drugs in human whole blood. (12907250)
2003
30
Desbuquois syndrome: clinical and radiological report of the first two Chinese cases from a consanguineous family. (14629506)
2003
31
Agonist- and protein kinase C-induced phosphorylation have similar functional consequences for gastrin-releasing peptide receptor signaling via Gq. (14500746)
2003
32
WRN helicase accelerates the transcription of ribosomal RNA as a component of an RNA polymerase I-associated complex. (11971179)
2002
33
Atypical pityriasis rubra pilaris associated with arthropathy and osteoporosis: a case report with 15-year follow-up. (11860571)
2002
34
Maleylacetoacetate isomerase (MAAI/GSTZ)-deficient mice reveal a glutathione-dependent nonenzymatic bypass in tyrosine catabolism. (12052898)
2002
35
Urethral stricture associated with malacoplakia: a case report and review of the literature. (11164174)
2001
36
Squamous cell carcinoma developing in necrobiosis lipoidica. (11437865)
2001
37
Vascular endothelial cells and smooth muscle cells differ in expression of Fas and Fas ligand and in sensitivity to Fas ligand-induced cell death: implications for vascular disease and therapy. (10669625)
2000
38
Nebulised steroid in the treatment of croup: a systematic review of randomised controlled trials. (10750214)
2000
39
Multi-dimensional QSAR in drug research. Predicting binding affinities, toxicity and pharmacokinetic parameters. (11127962)
2000
40
Nuclear export in plants. Use of geminivirus movement proteins for a cell-based export assay. (10402428)
1999
41
Neostigmine for the treatment of acute colonic pseudo-obstruction. (10403850)
1999
42
Silicosis and workers' compensation in New Jersey. (8749739)
1995
43
Decreased expression of hepatocyte nuclear factor 3 alpha during the acute-phase response influences transthyretin gene transcription. (7862129)
1995
44
A single residue determines the distinct pharmacology of rat and human natriuretic peptide receptor-C. (7911802)
1994
45
Modulatory effects of tamoxifen and recombinant human alpha-interferon on doxorubicin resistance. (8100483)
1993
46
Tyrosine phosphorylation of receptor beta subunits and common substrates in response to interleukin-3 and granulocyte-macrophage colony-stimulating factor. (1400495)
1992
47
Domain structure of human 72-kDa gelatinase/type IV collagenase. Characterization of proteolytic activity and identification of the tissue inhibitor of metalloproteinase-2 (TIMP-2) binding regions. (1322396)
1992
48
Macrophage colony-stimulating factor gene expression in vascular cells and in experimental and human atherosclerosis. (1739124)
1992
49
Recurrent, familial Reye-like syndrome with a new complex amino and organic aciduria. (2120061)
1990
50
Non-filarial elephantiasis. (6105431)
1980

Variations for Chronic Laryngitis

About this section

Expression for genes affiliated with Chronic Laryngitis

About this section
Search GEO for disease gene expression data for Chronic Laryngitis.

Pathways for genes affiliated with Chronic Laryngitis

About this section

Pathways related to Chronic Laryngitis according to GeneCards Suite gene sharing:

idSuper pathwaysScoreTop Affiliating Genes
19.8ATP4A, HRH2
29.4CYP2C19, GP5

GO Terms for genes affiliated with Chronic Laryngitis

About this section

Biological processes related to Chronic Laryngitis according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1potassium ion importGO:00101079.7ATP12A, ATP4A
2potassium ion transportGO:00068139.4ATP12A, ATP4A

Sources for Chronic Laryngitis

About this section
2CDC
14ExPASy
15FDA
16FMA
24GTR
25HGMD
26HMDB
27ICD10
28ICD10 via Orphanet
29ICD9CM
30IUPHAR
31KEGG
34MedGen
36MeSH
37MESH via Orphanet
38MGI
41NCI
42NCIt
43NDF-RT
46NINDS
47Novoseek
49OMIM
50OMIM via Orphanet
54PubMed
55QIAGEN
60SNOMED-CT via Orphanet
64Tumor Gene Family of Databases
65UMLS
66UMLS via Orphanet